Guangna Liu

2.5k total citations · 5 hit papers
25 papers, 2.1k citations indexed

About

Guangna Liu is a scholar working on Biomedical Engineering, Molecular Biology and Immunology. According to data from OpenAlex, Guangna Liu has authored 25 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biomedical Engineering, 10 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Guangna Liu's work include Nanoplatforms for cancer theranostics (12 papers), Cancer Research and Treatments (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). Guangna Liu is often cited by papers focused on Nanoplatforms for cancer theranostics (12 papers), Cancer Research and Treatments (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). Guangna Liu collaborates with scholars based in China, Australia and United Kingdom. Guangna Liu's co-authors include Guangjun Nie, Yinlong Zhang, Yao Li, Junchao Xu, Xiao Zhao, Keman Cheng, Jiaqi Xu, Huan Min, Jing Wang and Jian Shi and has published in prestigious journals such as Advanced Materials, Nature Communications and ACS Nano.

In The Last Decade

Guangna Liu

25 papers receiving 2.1k citations

Hit Papers

Biomimetic Metal–Organic Framework Nanoparticles for Coop... 2019 2026 2021 2023 2019 2022 2023 2022 2025 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Biomimetic Metal–Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy
    2019 356 citations Huan Min, Jing Wang et al. Advanced Materials profile →
  2. Engineered Bacterial Outer Membrane Vesicles as Controllable Two‐Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor Immunotherapy
    2022 157 citations Qingqing Feng, Xiaotu Ma et al. Advanced Materials profile →
  3. Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field
    2023 151 citations Xiaotu Ma, Xiaolong Liang et al. Nature Communications profile →
  4. Probiotic‐Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut Microbiome
    2022 134 citations Jiaqi Xu, Junchao Xu et al. Advanced Materials profile →
  5. Engineered Bacterial Outer Membrane Vesicles‐Based Doxorubicin and CD47‐siRNA Co‐Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastoma
    2025 21 citations Haoyu You, Shilin Zhang et al. Advanced Materials profile →

Peers

Guangna Liu
Yingqiu Qi China
Junchao Xu China
Jiaqi Xu China
Hao Qin China
Yujing Li China
En Ren China
Shisong Han China
Ann‐Marie Broome United States
Zhenjia Wang United States
Yao Jiang China
Yingqiu Qi China
Guangna Liu
Citations per year, relative to Guangna Liu Guangna Liu (= 1×) peers Yingqiu Qi

Countries citing papers authored by Guangna Liu

Since Specialization
Citations

This map shows the geographic impact of Guangna Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangna Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangna Liu more than expected).

Fields of papers citing papers by Guangna Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangna Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangna Liu. The network helps show where Guangna Liu may publish in the future.

Co-authorship network of co-authors of Guangna Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Guangna Liu. A scholar is included among the top collaborators of Guangna Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangna Liu. Guangna Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xu, Liting Chen, Guangna Liu, et al.. (2025). Tailoring an intravenously injectable oncolytic virus for augmenting radiotherapy. Cell Reports Medicine. 6(5). 102078–102078. 4 indexed citations
2.
You, Haoyu, Shilin Zhang, Yiwen Zhang, et al.. (2025). Engineered Bacterial Outer Membrane Vesicles‐Based Doxorubicin and CD47‐siRNA Co‐Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastoma. Advanced Materials. 37(15). e2418053–e2418053. 21 indexed citations breakdown →
3.
Cheng, Keman, Nana Ma, Jie Liang, et al.. (2023). Site‐Specific Modification of Virus‐Like Particles for Exogenous Tumor Antigen Display and Minimizing Preexisting Immunity. Small. 19(23). e2300125–e2300125. 9 indexed citations
4.
Ma, Xiaotu, Xiaolong Liang, Yao Li, et al.. (2023). Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field. Nature Communications. 14(1). 1606–1606. 151 indexed citations breakdown →
5.
Chen, Xu, Keman Cheng, Xinwei Wang, et al.. (2023). Antigen-capturing oncolytic adenoviruses along with IDO blockade for improved tumor immunotherapy. Nano Today. 51. 101922–101922. 11 indexed citations
6.
Ma, Nana, Keman Cheng, Qingqing Feng, et al.. (2023). Nanoscale Organization of TRAIL Trimers using DNA Origami to Promote Clustering of Death Receptor and Cancer Cell Apoptosis. Small. 19(23). e2206160–e2206160. 17 indexed citations
7.
Xu, Jiaqi, Junchao Xu, Tongfei Shi, et al.. (2022). Probiotic‐Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut Microbiome. Advanced Materials. 35(3). e2207890–e2207890. 134 indexed citations breakdown →
8.
Feng, Qingqing, Xiaotu Ma, Keman Cheng, et al.. (2022). Engineered Bacterial Outer Membrane Vesicles as Controllable Two‐Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor Immunotherapy. Advanced Materials. 34(40). e2206200–e2206200. 157 indexed citations breakdown →
9.
Liang, Jie, Keman Cheng, Yao Li, et al.. (2021). Personalized cancer vaccines from bacteria-derived outer membrane vesicles with antibody-mediated persistent uptake by dendritic cells. Fundamental Research. 2(1). 23–36. 29 indexed citations
10.
Li, Suping, Yinlong Zhang, Shih‐Hsin Ho, et al.. (2020). Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles. Nature Biomedical Engineering. 4(7). 732–742. 124 indexed citations
11.
Li, Yao, Ruifang Zhao, Keman Cheng, et al.. (2020). Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy via Immune Activation and Checkpoint Inhibition. ACS Nano. 14(12). 16698–16711. 224 indexed citations
12.
Min, Huan, Jing Wang, Yingqiu Qi, et al.. (2019). Biomimetic Metal–Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy. Advanced Materials. 31(15). e1808200–e1808200. 356 indexed citations breakdown →
13.
Xu, Jiaqi, Yinlong Zhang, Junchao Xu, et al.. (2019). Reversing tumor stemness via orally targeted nanoparticles achieves efficient colon cancer treatment. Biomaterials. 216. 119247–119247. 51 indexed citations
14.
Liu, Guangna, Xiao Zhao, Yinlong Zhang, et al.. (2019). Engineering Biomimetic Platesomes for pH‐Responsive Drug Delivery and Enhanced Antitumor Activity. Advanced Materials. 31(32). e1900795–e1900795. 199 indexed citations
15.
Xu, Junchao, Yinlong Zhang, Jiaqi Xu, et al.. (2019). Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models. Advanced Materials. 32(4). e1905145–e1905145. 192 indexed citations
16.
Li, Yao, Xiao Zhao, Xiaoli Liu, et al.. (2019). A Bioinspired Nanoprobe with Multilevel Responsive T1‐Weighted MR Signal‐Amplification Illuminates Ultrasmall Metastases. Advanced Materials. 32(4). e1906799–e1906799. 80 indexed citations
17.
Zhang, Yinlong, Guangna Liu, Jingyan Wei, & Guangjun Nie. (2018). Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy. Frontiers of Medicine. 12(6). 667–677. 38 indexed citations
18.
Shi, Quanwei, Yinlong Zhang, Shaoli Liu, et al.. (2018). Specific tissue factor delivery using a tumor-homing peptide for inducing tumor infarction. Biochemical Pharmacology. 156. 501–510. 24 indexed citations
19.
Zhang, Yinlong, Jingyan Wei, Jiaqi Xu, et al.. (2017). Suppression of Tumor Energy Supply by Liposomal Nanoparticle-Mediated Inhibition of Aerobic Glycolysis. ACS Applied Materials & Interfaces. 10(3). 2347–2353. 47 indexed citations
20.
Guan, Shuyan, et al.. (2011). Production of high-amylose maize lines using RNA interference in sbe2a. AFRICAN JOURNAL OF BIOTECHNOLOGY. 10(68). 15229–15237. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingqiu Qi Breakdown of academic impact, for papers by Junchao Xu Breakdown of academic impact, for papers by Jiaqi Xu Breakdown of academic impact, for papers by Hao Qin Breakdown of academic impact, for papers by Yujing Li Breakdown of academic impact, for papers by En Ren Breakdown of academic impact, for papers by Shisong Han Breakdown of academic impact, for papers by Ann‐Marie Broome Breakdown of academic impact, for papers by Zhenjia Wang Breakdown of academic impact, for papers by Yao Jiang
Rankless by CCL
2026